These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Therapeutical targets for revert liver fibrosis]. García B L; Gálvez G J; Armendáriz B J Rev Med Chil; 2007 Jun; 135(6):783-91. PubMed ID: 17728907 [TBL] [Abstract][Full Text] [Related]
3. [Liver fibrosis]. Chevallier M; Paradis V; Bedossa P Ann Pathol; 1995; 15(5):372-9. PubMed ID: 8540923 [No Abstract] [Full Text] [Related]
4. [Extracellular matrix of the liver: structure and regulation]. Bédossa P Gastroenterol Clin Biol; 1994; 18(6-7):556-67. PubMed ID: 7875415 [No Abstract] [Full Text] [Related]
5. [Pathophysiology of hepatic fibrosis]. Vaĺková M Vnitr Lek; 2002 Jan; 48(1):27-33. PubMed ID: 11852583 [TBL] [Abstract][Full Text] [Related]
6. Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic. Muddu AK; Guha IN; Elsharkawy AM; Mann DA Int J Biochem Cell Biol; 2007; 39(4):695-714. PubMed ID: 17110155 [TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-2 activation in human hepatic fibrosis regulation by cell-matrix interactions. Préaux AM; Mallat A; Nhieu JT; D'Ortho MP; Hembry RM; Mavier P Hepatology; 1999 Oct; 30(4):944-50. PubMed ID: 10498646 [TBL] [Abstract][Full Text] [Related]
11. Liver extracellular matrix in health and disease. Bedossa P; Paradis V J Pathol; 2003 Jul; 200(4):504-15. PubMed ID: 12845618 [TBL] [Abstract][Full Text] [Related]
12. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved. Guyot C; Lepreux S; Combe C; Doudnikoff E; Bioulac-Sage P; Balabaud C; Desmoulière A Int J Biochem Cell Biol; 2006 Feb; 38(2):135-51. PubMed ID: 16257564 [TBL] [Abstract][Full Text] [Related]
13. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Elsharkawy AM; Oakley F; Mann DA Apoptosis; 2005 Oct; 10(5):927-39. PubMed ID: 16151628 [TBL] [Abstract][Full Text] [Related]
14. [Liver fibrosis and cirrhosis: are they reversible?]. Kershenobich D Rev Gastroenterol Mex; 2004 Nov; 69 Suppl 3():149-51. PubMed ID: 16881220 [No Abstract] [Full Text] [Related]
15. Fibrosis and cirrhosis reversibility - molecular mechanisms. Gieling RG; Burt AD; Mann DA Clin Liver Dis; 2008 Nov; 12(4):915-37, xi. PubMed ID: 18984474 [TBL] [Abstract][Full Text] [Related]
20. [The importance of explorations on the pathophysiological mechanisms and treatment methods for liver fibrosis]. Liu P Zhonghua Gan Zang Bing Za Zhi; 2010 Aug; 18(8):561-2. PubMed ID: 20825704 [No Abstract] [Full Text] [Related] [Next] [New Search]